Skip to main content
Premium Trial:

Request an Annual Quote

LunaPBC Nabs $4.6M in Funding

NEW YORK (GenomeWeb) – LunaPBC has announced $4.6 million in new funding.

The La Jolla, California-based firm said the funds will be used to accelerate research partnerships; bring on new partners, including Genetic Alliance; and expand marketing and development of its LunaDNA genomic and health data sharing platform.

The round was led by Arch Venture Partners, Bain Capital Ventures, F-Prime Capital, Illumina Ventures, and Osage University Partners.

"It's the right time to reimagine the role and rights of individuals across the globe in driving health discovery with their life data," Yumin Choi, partner at Bain Capital Ventures, said in a statement. "We are excited about LunaPBC's people-first model, which empowers individuals as valued partners, not just research subjects; will create a deeper dataset with environment-specific and people-reported data; and has an intentional public benefit component to ensure long-standing impact in our communities."

LunaPBC said it has raised $7.6 million to date. In December 2017, the firm raised $2 million in seed funding.

CEO and co-founder Bob Kain also announced new corporate advisors: Jason Paragas of Integral Health; Doug Harrison, founder of Harrison Group; and Chris Cabou, formerly general counsel at Illumina.

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.